I did a little math in my head the other day.  At the AGM DM apparently said the company was worth about $4B.  So, I cut that in half to $2B.  Then we got the CKD substudy and VD results and I added $0.5B for each.  Then I added another $1B for the BTD, which brings us back to $4B.  Then I cut that in half to get $2B. So, as you can see my very scientific analysis arrives at a a very conservative valuation of $2B. :)

Kidding aside, it does seem that a company like this with 20 years of research behind it should attract, given the results, a valuation like $2B or more, especially in this industry.  There's a lot of noise going on right now with Covid-19, oil prices, elections, markets, etc. but any BP looking at RVX is thinking long term.  There will always be noise of some type but this too shall pass.  It always does.  The CKD data that will soon be presented will be presented and how it's presented doesn't matter.  The results will still speak for itself.

Looking forward to the 26th.  Every bit of good news will help and will increase the company's valuation, if not on the exchanges then for sure as a a viable buyout target......whenever that may be.